Excretion and distribution studies with radioisotope-labeled alkylating drugs in cancer patients
- 1 September 1961
- Vol. 14 (5) , 953-956
- https://doi.org/10.1002/1097-0142(196109/10)14:5<953::aid-cncr2820140507>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- BUSULFAN (1,4‐DIMETHANESULFONYLOXYBUTANE, MYLERAN): SUMMARY OF CLINICAL, RESULTSAnnals of the New York Academy of Sciences, 1958
- DISTRIBUTION AND FATE OF ALKYLATING AGENTSAnnals of the New York Academy of Sciences, 1958
- SUMMARY OF RESULTS OBTAINED WITH TEMAnnals of the New York Academy of Sciences, 1958
- NECESSARY CRITERIA FOR THE COMPARATIVE EVALUATION OF ALKYLATING AGENTS IN CLINICAL CANCER CHEMOTHERAPYAnnals of the New York Academy of Sciences, 1958
- Clinical studies on triethylenephosphoramide and diethylenephosphoramide, compounds with nitrogen-mustard-like activityCancer, 1953